Delhi High Court stays regulator’s curb on ORS branding in relief for J&J arm

This article covers a decision by the Delhi High Court granting interim relief to a subsidiary of Johnson & Johnson (JNTL Consumer Health) by staying two orders of the Food Safety and Standards Authority of India (FSSAI) that prohibited the use of the term “ORS” in branding of beverages. The Court observed that the regulatory directive appeared “ex facie arbitrary and unreasonable” and directed that no coercive action be taken until the company has been heard. The article explains that JNTL argued that prior FSSAI orders (in 2022 and 2024) had permitted use of “ORS” with prefix or suffix in registered trademarks subject to disclaimers, and that their product stocks (worth ~₹155-180 crore) would face serious commercial harm if enforcement proceeded. The piece highlights the tension between regulatory goals of consumer protection (avoiding misleading brand names) and commercial/trademark rights of companies, and underscores how procedural safeguards such as hearing and stakeholder consultation are key in regulatory interventions.